QQQ   308.28 (+2.45%)
AAPL   149.32 (+2.67%)
MSFT   259.42 (+2.64%)
META   182.47 (+19.17%)
GOOGL   106.67 (+6.21%)
AMZN   110.30 (+4.90%)
TSLA   189.64 (+4.54%)
NVDA   213.86 (+2.12%)
NIO   12.10 (+0.00%)
BABA   110.01 (-2.49%)
AMD   85.76 (+1.32%)
T   20.10 (-0.40%)
MU   63.10 (+0.80%)
F   14.20 (+2.97%)
CGC   3.15 (+2.27%)
GE   82.42 (+0.12%)
DIS   110.25 (+0.79%)
AMC   6.16 (+7.88%)
PFE   43.83 (-0.32%)
PYPL   86.61 (+4.46%)
NFLX   361.64 (-0.10%)
QQQ   308.28 (+2.45%)
AAPL   149.32 (+2.67%)
MSFT   259.42 (+2.64%)
META   182.47 (+19.17%)
GOOGL   106.67 (+6.21%)
AMZN   110.30 (+4.90%)
TSLA   189.64 (+4.54%)
NVDA   213.86 (+2.12%)
NIO   12.10 (+0.00%)
BABA   110.01 (-2.49%)
AMD   85.76 (+1.32%)
T   20.10 (-0.40%)
MU   63.10 (+0.80%)
F   14.20 (+2.97%)
CGC   3.15 (+2.27%)
GE   82.42 (+0.12%)
DIS   110.25 (+0.79%)
AMC   6.16 (+7.88%)
PFE   43.83 (-0.32%)
PYPL   86.61 (+4.46%)
NFLX   361.64 (-0.10%)
QQQ   308.28 (+2.45%)
AAPL   149.32 (+2.67%)
MSFT   259.42 (+2.64%)
META   182.47 (+19.17%)
GOOGL   106.67 (+6.21%)
AMZN   110.30 (+4.90%)
TSLA   189.64 (+4.54%)
NVDA   213.86 (+2.12%)
NIO   12.10 (+0.00%)
BABA   110.01 (-2.49%)
AMD   85.76 (+1.32%)
T   20.10 (-0.40%)
MU   63.10 (+0.80%)
F   14.20 (+2.97%)
CGC   3.15 (+2.27%)
GE   82.42 (+0.12%)
DIS   110.25 (+0.79%)
AMC   6.16 (+7.88%)
PFE   43.83 (-0.32%)
PYPL   86.61 (+4.46%)
NFLX   361.64 (-0.10%)
QQQ   308.28 (+2.45%)
AAPL   149.32 (+2.67%)
MSFT   259.42 (+2.64%)
META   182.47 (+19.17%)
GOOGL   106.67 (+6.21%)
AMZN   110.30 (+4.90%)
TSLA   189.64 (+4.54%)
NVDA   213.86 (+2.12%)
NIO   12.10 (+0.00%)
BABA   110.01 (-2.49%)
AMD   85.76 (+1.32%)
T   20.10 (-0.40%)
MU   63.10 (+0.80%)
F   14.20 (+2.97%)
CGC   3.15 (+2.27%)
GE   82.42 (+0.12%)
DIS   110.25 (+0.79%)
AMC   6.16 (+7.88%)
PFE   43.83 (-0.32%)
PYPL   86.61 (+4.46%)
NFLX   361.64 (-0.10%)
NASDAQ:CALA

Calithera Biosciences - CALA Stock Forecast, Price & News

$0.15
-0.22 (-58.92%)
(As of 02/2/2023 10:03 AM ET)
Add
Compare
Today's Range
$0.11
$0.34
50-Day Range
$0.37
$3.62
52-Week Range
$0.11
$13.38
Volume
14,424 shs
Average Volume
673,010 shs
Market Capitalization
$730,500.00
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$18.67

Calithera Biosciences MarketRank™ Forecast

Analyst Rating
Hold
2.33 Rating Score
Upside/​Downside
9,186.9% Upside
$18.67 Price Target
Short Interest
Bearish
8.73% of Float Sold Short
Dividend Strength
N/A
Sustainability
-1.11
Upright™ Environmental Score
News Sentiment
0.22mentions of Calithera Biosciences in the last 14 days
Based on 3 Articles This Week
Insider Trading
Selling Shares
$47,320 Sold Last Quarter
Proj. Earnings Growth
Growing
From ($8.62) to ($3.17) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.22 out of 5 stars


CALA stock logo

About Calithera Biosciences (NASDAQ:CALA) Stock

Calithera Biosciences, Inc. is a clinical-stage biopharmaceutical company, which focuses on discovering and developing small molecule drugs that target novel and critical metabolic pathways in tumor and cancer-fighting immune cells. It offers programs such as Pipeline, Glutaminase Inhibitor, and Arginase Inhibitor. The company was founded by James A. Wells and Susan M. Molineaux on March 9, 2010 and is headquartered in South San Francisco, CA.

Receive CALA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Calithera Biosciences and its competitors with MarketBeat's FREE daily newsletter.

CALA Stock News Headlines

Know Your Profit Potential BEFORE You Trade!
I’m Chuck Hughes, ten-time trading champion and author of the coveted e-book, “Options Trading Made Easy”, the strategy guide that will teach you to calculate your trade’s profit potential before you risk any capital. Click here for a free copy now! pixel
Calithera Biosciences to Liquidate >CALA
Know Your Profit Potential BEFORE You Trade!
I’m Chuck Hughes, ten-time trading champion and author of the coveted e-book, “Options Trading Made Easy”, the strategy guide that will teach you to calculate your trade’s profit potential before you risk any capital. Click here for a free copy now! pixel
CALA Calithera Biosciences, Inc.
Calithera Biosciences Inc
3 Penny Stocks With Surprisingly Superior Fundamentals
See More Headlines
Receive CALA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Calithera Biosciences and its competitors with MarketBeat's FREE daily newsletter.

CALA Company Calendar

Last Earnings
11/14/2022
Today
2/02/2023
Next Earnings (Estimated)
3/30/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:CALA
Fax
N/A
Employees
92
Year Founded
2010

Price Target and Rating

Average Stock Price Forecast
$18.67
High Stock Price Forecast
$30.00
Low Stock Price Forecast
$8.00
Forecasted Upside/Downside
+12,344.4%
Consensus Rating
Hold
Rating Score (0-4)
2.33
Research Coverage
3 Analysts

Profitability

Net Income
$-115,090,000.00
Pretax Margin
-1,530.22%

Debt

Sales & Book Value

Annual Sales
$9.75 million
Book Value
$2.17 per share

Miscellaneous

Free Float
4,544,000
Market Cap
$730,500.00
Optionable
Optionable
Beta
1.06

Social Links


Key Executives

  • Susan M. MolineauxSusan M. Molineaux
    President, Chief Executive Officer & Director
  • Stephanie Wong
    CFO, Secretary & Chief Accounting Officer
  • Susan B Demo
    Senior Vice President-R&D Operations
  • Francesco Parlati
    Senior Vice President-Research
  • Emil T. Kuriakose
    Chief Medical Officer













CALA Stock - Frequently Asked Questions

Should I buy or sell Calithera Biosciences stock right now?

3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Calithera Biosciences in the last year. There are currently 2 hold ratings and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" CALA shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CALA, but not buy additional shares or sell existing shares.
View CALA analyst ratings
or view top-rated stocks.

What is Calithera Biosciences' stock price forecast for 2023?

3 Wall Street research analysts have issued 12 month price objectives for Calithera Biosciences' shares. Their CALA share price forecasts range from $8.00 to $30.00. On average, they anticipate the company's stock price to reach $18.67 in the next year. This suggests a possible upside of 5,012.8% from the stock's current price.
View analysts price targets for CALA
or view top-rated stocks among Wall Street analysts.

How have CALA shares performed in 2023?

Calithera Biosciences' stock was trading at $3.26 at the start of the year. Since then, CALA stock has decreased by 88.8% and is now trading at $0.3651.
View the best growth stocks for 2023 here
.

When is Calithera Biosciences' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, March 30th 2023.
View our CALA earnings forecast
.

How were Calithera Biosciences' earnings last quarter?

Calithera Biosciences, Inc. (NASDAQ:CALA) released its earnings results on Monday, November, 14th. The biotechnology company reported ($2.01) earnings per share for the quarter, missing analysts' consensus estimates of ($1.99) by $0.02.

When did Calithera Biosciences' stock split?

Shares of Calithera Biosciences reverse split before market open on Wednesday, June 15th 2022. The 1-20 reverse split was announced on Wednesday, June 15th 2022. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, June 15th 2022. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

What other stocks do shareholders of Calithera Biosciences own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Calithera Biosciences investors own include Puma Biotechnology (PBYI), Incyte (INCY), BioMarin Pharmaceutical (BMRN), (MDVN) (MDVN), Celadon Group (CGI), Dynavax Technologies (DVAX), Rigel Pharmaceuticals (RIGL), First Solar (FSLR), Plug Power (PLUG) and Sorrento Therapeutics (SRNE).

What is Calithera Biosciences' stock symbol?

Calithera Biosciences trades on the NASDAQ under the ticker symbol "CALA."

Who are Calithera Biosciences' major shareholders?

Calithera Biosciences' stock is owned by many different institutional and retail investors. Top institutional investors include Concourse Financial Group Securities Inc. (0.00%). Insiders that own company stock include Bvf Partners L P/Il, Deepika Pakianathan, Keith Orford, Stephanie Wong and Susan Molineaux.
View institutional ownership trends
.

How do I buy shares of Calithera Biosciences?

Shares of CALA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Calithera Biosciences' stock price today?

One share of CALA stock can currently be purchased for approximately $0.37.

How much money does Calithera Biosciences make?

Calithera Biosciences (NASDAQ:CALA) has a market capitalization of $1.78 million and generates $9.75 million in revenue each year. The biotechnology company earns $-115,090,000.00 in net income (profit) each year or ($25.60) on an earnings per share basis.

How can I contact Calithera Biosciences?

Calithera Biosciences' mailing address is 343 OYSTER POINT BLVD. SUITE 200, SOUTH SAN FRANCISCO CA, 94080. The official website for the company is www.calithera.com. The biotechnology company can be reached via phone at (650) 870-1000 or via email at ir@calithera.com.

This page (NASDAQ:CALA) was last updated on 2/2/2023 by MarketBeat.com Staff